MA
PPH icon

Mutual Advisors’s VanEck Pharmaceutical ETF PPH Stock Holding History

Mutual Advisors’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,488
Closed -$390K – 1192
2025
Q1 		$390K Sell
4,488
-875
-16% -$78.8K 0.01% 811
2024
Q4 		$464K Hold
5,363
– – 0.01% 725
2024
Q3 		$496K Sell
5,363
-700
-12% -$66.5K 0.01% 708
2024
Q2 		$565K Buy
6,063
+750
+14% +$67K 0.02% 657
2024
Q1 		$482K Buy
+5,313
New +$465K 0.02% 703
2018
Q2 		– Sell
-14,485
Closed -$823K – 429
2018
Q1 		$823K Buy
+14,485
New +$865K 0.21% 158

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AWC
Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Mutual Advisors's PPH Position: Q2 2025 in Review

Mutual Advisors sold out of VanEck Pharmaceutical ETF (PPH) in Q2 2025, closing a stake of 4,488 shares — an estimated $390K sold.

Mutual Advisors first reported a position in PPH in Q1 2018 and held it in 6 quarters. The position peaked at $823K in Q1 2018. 129 funds tracked by Wall St. Rank hold PPH as of Q2 2025.

  • Mutual Advisors reported no remaining VanEck Pharmaceutical ETF position as of Q2 2025 after selling out during the quarter.
  • Mutual Advisors sold 4,488 VanEck Pharmaceutical ETF shares in Q2 2025, an estimated $390K.
  • Mutual Advisors first reported a position in VanEck Pharmaceutical ETF in Q1 2018 and held it in 6 quarters.
  • Mutual Advisors's VanEck Pharmaceutical ETF position peaked at $823K in Q1 2018.
  • 129 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2025.

Based on Mutual Advisors's 13F filing for Q2 2025, filed 28 Jul 2025.